Accessibility Menu
Nu Skin Enterprises logo

Nu Skin Enterprises(NYSE) NUS

Market Cap$233.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1996)-67%
5 Year-89%
1 Year-58%
1 Month-10%
$4.60
-3.97%
-0.19Today
Nu Skin Enterprises last closing stock price
MetricPriceDate
Last closeUSD 4.792026-08-19
Nu Skin Enterprises stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.24%USD 4.852026-08-12
1 month-10.13%USD 5.332026-07-20
3 month-18.13%USD 5.852026-05-21
Year to date-49.35%USD 9.462025-12-31
1 year-58.47%USD 11.532025-08-19
3 year-78.11%USD 21.882023-08-18
5 year-88.91%USD 43.202021-08-20
Since inception-66.92%USD 14.481996-11-22

Nu Skin Enterprises Financials at a Glance

Market Cap

$233.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.38B

Net Income (TTM)

-$216.39M

EPS (TTM)

-$4.47

P/E Ratio

-1.07

Dividend

$0.24

Beta (Volatility)

0.89 (Low)

Price

$4.60

Volume

143,981.784

Open

$4.76

Previous Close

$4.79

Daily Range

$4.60 - $4.78

52-Week Range

$4.49 - $14.62

Estimated Earnings Date

Nov 5, 2026

NUS: Motley Fool Moneyball Superscore

39

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nu Skin Enterprises

Nu Skin Enterprises, Inc. sells beauty and health products globally. It helps people care for their skin and manage their weight. The company sells items through online stores and independent distributors.

What's in the Bag?

  • Skincare Systems: Line of devices and treatments designed for skin cleansing and anti-aging.
  • Nutritional Supplements: Dietary products and daily systems intended to support general wellness.
  • Weight Management: Specialized programs and supplements focused on body contouring and control.
  • Manufacturing Services: Production and development of products for third-party customers through the Rhyz segment.

Strategic Moves and Shifts

  • Sold the Mavely business in January 2025 for a pre-tax gain of approximately $176.2 million.
  • Acquired the remaining 30% interest in LifeDNA in the first quarter of 2026 for $6.5 million.
  • Started the process to wind down the separate BeautyBio business during the first quarter of 2026.
  • Planned a full market opening in India for the first half of 2027.

How the Business Operates

The company operates a network of retail stores and service centers in Mainland China while using e-commerce platforms in other regions. It maintains a multi-level sales force consisting of Customers, Paid Affiliates, and Sales Leaders across seven geographic segments.

Essential Financial Data

  • Revenue was $320.1 million in the second quarter of 2026, down 17.1% year over year.
  • Net loss was $249.8 million in the second quarter of 2026, compared to net income of $21.1 million in the prior-year period.
  • Cash and cash equivalents totaled $191.4 million as of June 30, 2026.
  • Market capitalization was $255.6 million in the second quarter of 2026, a 35.3% decrease year over year.
  • Capital expenditures are estimated to be $40 million to $60 million for 2026.

Bottom Line

Nu Skin is transitioning its business model by focusing on intelligent wellness platforms and manufacturing expansion. The company is currently navigating macroeconomic challenges and organizational restructuring to stabilize its global operations.

AI Generated • Aug 11, 2026

Industry

Personal Products

Employees

8,600

CEO

Ryan S. Napierski, MBA

Headquarters

Provo, UT 84601, US

NUS Financials

Key Financial Metrics (TTM)

Gross Margin

69.19%

Operating Margin

-0.62%

Net Income Margin

-15.73%

Return on Equity

-29.42%

Return on Capital

7.77%

Return on Assets

-19.29%

Earnings Yield

-93.46%

Dividend Yield

5.01%

Payout Ratio

-5.39%

Stock Overview

Market Cap

$233.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

48.68M

Volume

143.98K

Avg. Volume

708.53K

Financials (TTM)

Gross Profit

$951.49M

Operating Income

-$8.57M

EBITDA

$39.32M

Operating Cash Flow

$50.81M

Capital Expenditure

-$40.03M

Free Cash Flow

$10.78M

Cash & ST Invst.

$189.64M

Total Debt

$263.74M

Nu Skin Enterprises Performance Analysis

Nu Skin Enterprises annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,225,659,000-17.4%
20232023-12-31USD 1,969,131,000-11.5%
20242024-12-31USD 1,732,084,000-12.0%
20252025-12-31USD 1,485,159,000-14.3%
Nu Skin Enterprises sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-5.7%
Q42025-12-311.7%
Q12026-03-31-13.4%
Q22026-06-30-0.2%
Nu Skin Enterprises annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 2.07-27.6%
20232023-12-31USD 0.17-91.7%
20242024-12-31USD -2.95N/A
20252025-12-31USD 3.18N/A
Nu Skin Enterprises sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-20.9%
Q42025-12-31-14.7%
Q12026-03-31-87.2%
Q22026-06-30-13917.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$320.11M

-17.1%

Gross Profit

$218.33M

-17.8%

Gross Margin

68.20%

N/A

Market Cap

$233.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$83.27K

N/A

Employees

2,800

N/A

Net Income

-$249.80M

-1282.8%

EBITDA

-$47.20M

-209.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$189.64M

-28.2%

Total Debt

$263.74M

-15.1%

Accounts Receivable

$48.90M

-18.1%

Inventory

$191.50M

+6.2%

Long Term Debt

$243.74M

-11.6%

Short Term Debt

$20.00M

-42.9%

Return on Assets

-19.29%

N/A

Return on Invested Capital

-0.99%

N/A

Free Cash Flow

$4.99M

-86.1%

Operating Cash Flow

$10.63M

-70.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BYNDBeyond Meat, Inc.
$14.93+6.04%
MGPIMGP Ingredients, Inc.
$17.85-1.25%
VSTAVasta Platform Limited
$4.90-1.61%
OTLYOatly Group AB
$13.83-1.07%

Trending Stocks

Symbol / CompanyPricePrice Chg
BITOProShares Trust - ProShares Bitcoin ETF
$9.77+0.06%
IBITiShares Bitcoin Trust
$40.96+0.06%
SPCXSpace Exploration Technologies
$130.98-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.89-0.03%

Questions About NUS

What is the current price of Nu Skin Enterprises?

Nu Skin Enterprises is trading at $4.62 per share.

What is the 52-week range for Nu Skin Enterprises?

Over the past 52 weeks, Nu Skin Enterprises has traded between $4.49 and $14.62.

How much debt does Nu Skin Enterprises have?

As of the most recent reporting period, Nu Skin Enterprises reported total debt of $263.74M.

How much cash does Nu Skin Enterprises have on hand?

Nu Skin Enterprises reported $189.64M in cash and cash equivalents in its most recent financial results.

What is Nu Skin Enterprises’s dividend yield?

Nu Skin Enterprises currently has a dividend yield of 5.01%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.